Logo image of CDT

CDT EQUITY INC (CDT) Stock Overview

NASDAQ:CDT - US20678X3044 - Common Stock

1.68 USD
+0.14 (+9.09%)
Last: 8/22/2025, 8:00:02 PM
1.65 USD
-0.03 (-1.79%)
After Hours: 8/22/2025, 8:00:02 PM

CDT Key Statistics, Chart & Performance

Key Statistics
52 Week High274.8
52 Week Low1.47
Market Cap5.14M
Shares3.06M
Float2.74M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-164.39
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10
IPO02-03 2022-02-03
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services


CDT short term performance overview.The bars show the price performance of CDT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60 -80

CDT long term performance overview.The bars show the price performance of CDT in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CDT is 1.68 USD. In the past month the price decreased by -16%. In the past year, price decreased by -99.32%.

CDT EQUITY INC / CDT Daily stock chart

CDT Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 22.84 188.80B
DHR DANAHER CORP 28.13 151.66B
A AGILENT TECHNOLOGIES INC 22.52 34.55B
IQV IQVIA HOLDINGS INC 16.67 32.50B
MTD METTLER-TOLEDO INTERNATIONAL 32.31 27.22B
WAT WATERS CORP 24.71 17.99B
WST WEST PHARMACEUTICAL SERVICES 35.61 17.82B
ILMN ILLUMINA INC 24.47 15.65B
TEM TEMPUS AI INC N/A 13.99B
ICLR ICON PLC 13.29 13.67B
MEDP MEDPACE HOLDINGS INC 34.47 13.02B
RVTY REVVITY INC 19.25 10.93B

About CDT

Company Profile

CDT logo image Conduit Pharmaceuticals Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Naples Florida, Florida and currently employs 6 full-time employees. The company went IPO on 2022-02-03. Conduit Pharmaceuticals, Inc. is a multi-asset clinical-stage, life science company. The firm facilitates the development and commercialization of clinical assets. The firm acquires and funds the development of Phase 2-ready assets, builds an integrated and advanced platform-driven approach powered by artificial intelligence (AI) and cybernetics, and seeks exit through third-party license deals following successful clinical trials. The Company’s asset pipeline includes AZD1656 (a Glucokinase Activator), AZD5658 (Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. The company is used as a treatment option for Hashimoto’s Thyroiditis. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), for the treatment, prevention, and prophylaxis of idiopathic male infertility.

Company Info

CDT EQUITY INC

4851 Tamiami Trail North, Suite 200

Naples Florida FLORIDA US

Employees: 6

CDT Company Website

CDT Investor Relations

Phone: 16464919132

CDT EQUITY INC / CDT FAQ

What is the stock price of CDT EQUITY INC today?

The current stock price of CDT is 1.68 USD. The price increased by 9.09% in the last trading session.


What is the ticker symbol for CDT EQUITY INC stock?

The exchange symbol of CDT EQUITY INC is CDT and it is listed on the Nasdaq exchange.


On which exchange is CDT stock listed?

CDT stock is listed on the Nasdaq exchange.


What is CDT EQUITY INC worth?

CDT EQUITY INC (CDT) has a market capitalization of 5.14M USD. This makes CDT a Nano Cap stock.


How many employees does CDT EQUITY INC have?

CDT EQUITY INC (CDT) currently has 6 employees.


Should I buy CDT EQUITY INC (CDT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CDT EQUITY INC (CDT) stock pay dividends?

CDT does not pay a dividend.


When does CDT EQUITY INC (CDT) report earnings?

CDT EQUITY INC (CDT) will report earnings on 2025-11-10.


What is the Price/Earnings (PE) ratio of CDT EQUITY INC (CDT)?

CDT EQUITY INC (CDT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-164.39).


What is the Short Interest ratio of CDT EQUITY INC (CDT) stock?

The outstanding short interest for CDT EQUITY INC (CDT) is 2.55% of its float. Check the ownership tab for more information on the CDT short interest.


CDT Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CDT Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to CDT. CDT has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CDT Financial Highlights

Over the last trailing twelve months CDT reported a non-GAAP Earnings per Share(EPS) of -164.39. The EPS decreased by -33448.06% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -264.94%
ROE -721.85%
Debt/Equity 0.99
Chartmill High Growth Momentum
EPS Q2Q%-2659%
Sales Q2Q%N/A
EPS 1Y (TTM)-33448.06%
Revenue 1Y (TTM)N/A

CDT Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

CDT Ownership

Ownership
Inst Owners1.3%
Ins Owners0.94%
Short Float %2.55%
Short Ratio0.26